EJVES Reviewer's guide  by unknown
Reviewer's quick guide to common statistical errors in scientific papers 
Design errors 
Sample size for human subjects 
Many studies are too small to detect 
even large effects (Table 1). 
 
Table 1: Guide to sample size 
Expected 
difference 
(p1-p2) 
Total sample 
size required* 
5% 1450-3200 
10% 440-820 
20% 140-210 
30% 80-100 
40% 50-60 
* 5% significance level, 80% power. Smaller numbers 
may be justified for rare outcomes (p1 <.1) 
 
Look for: 
• Clinical trials should always report 
sample size calculations 
• Authors with 'negative' results (i.e. 
found no difference) should not 
report equivalence unless 
sufficiently powered -"absence of 
evidence is not evidence of 
absence" 
 
Bias 
Randomisation is the best way of 
avoiding bias but it is not always possible 
or appropriate. 
 
Some biases affecting observational 
studies: 
Treatment-by-indication bias: different 
treatments are given to different groups 
of patients because of differences in their 
clinical condition. 
 
Historical controls: will tend to 
exaggerate treatment effect as recent 
patients benefit from improvements in 
health care over time and special 
attention as a study participant. Recent 
patients are also likely to be more 
restrictively selected. 
 
Retrospective data collection: availability 
and recording of events and patient 
characteristics may be related to the 
groups being compared. 
 
Ecological fallacy: an association 
observed between variables on an 
aggregate level does not necessarily 
represent the association that exists at 
the individual level. 
 
Some biases affecting observational 
studies and clinical trials: 
Selection bias: low response rate or high 
refusal rate – were patients that 
participated different to those that did 
not? 
 
Informative dropout – was follow-up 
curtailed for reasons connected to the 
primary outcome? If so, imbalance in 
dropout rates between the groups being 
compared will introduce bias. 
 
Bias in clinical trials: 
No-one should know what the next 
random allocation is going to be as this 
may affect whether or when the patient is 
entered into the trial. Using date of birth, 
hospital number, or simply 
alternating between treatments 
is therefore inappropriate. 
Central randomisation is ideal.  
 
Unblinded assessment of 
outcomes may be influenced by 
knowledge of the treatment 
group. 
 
Look for: 
• Appreciation and 
measures taken to reduce 
bias through study design 
• Selection of patients, 
collection of data, definition 
and assessment of 
outcome and, for clinical 
trials, method of 
randomisation should be 
clearly described 
• Number and reasons for 
withdrawal should be 
reported by treatment 
group 
• Appropriate analytic 
methods such as multiple 
regression should be used 
to adjust for differences 
between groups in 
observational studies 
• Authors should discuss 
likely biases and potential 
impact on their results 
 
Method comparison studies 
If different methods are 
evaluated by different observers 
then the method differences are 
confounded with observer 
differences. The study must be 
repeated with each observer 
using all methods. 
 
Analysis errors 
Failure to use a test for trend on 
ordered categories (e.g. age-
group). 
 
Dichotomizing continuous 
variables in the analysis 
(acceptable for descriptive 
purposes). 
  
Using methods for independent 
samples on paired or repeated 
measures data. An example is 
using both arms or legs of the 
same patient as if they were two 
independent observations. 
 
Using parametric methods (e.g. 
t-test, ANOVA or linear 
regression) when the outcome 
or residuals have not been 
verified as normally distributed. 
  
Over using hypothesis tests (P-
values) in preference to 
confidence intervals. 
 
One-tailed tests are very rarely 
appropriate. 
 
Failing to analyse clinical trials 
by intention-to-treat. 
 
Obscure statistical tests should be 
justified and referenced. 
 
Comparing P-values between subgroups 
instead of carrying out tests of interaction 
is incorrect. Some may wrongly conclude 
from these results that: 
P>0.05
P<0.05Subgroup A
Subgroup B
1
Treatment effect with 95% CI  
the subgroup affects response to 
treatment, based on comparing P-values. 
A test of interaction would show no 
evidence of any effect of the grouping on 
response. 
 
Correlating time series: any two variables 
that consistently rise, fall or remain 
constant over time will be correlated. 
'Detrended' series should be compared 
instead. 
 
Method comparison studies 
Correlation ≠ agreement 
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Higher correlation can be induced by 
including patients with extreme 
measurements. Limits of agreement 
should be calculated according to 
method of Bland and Altman. Adequate 
agreement between methods is a clinical 
not a statistical judgement. 
 
Multiple testing 
Conclusions should only be drawn from 
appropriate analyses of a small number 
of clear, pre-defined hypotheses. Results 
from post-hoc subgroup or risk-factor 
analyses should be treated as 
speculative. If many such tests have 
been carried out adjustment for multiple 
testing should be considered. 
 
Comparing groups at multiple time points 
should be avoided – a summary statistics 
approach or more complex statistical 
methods should be used instead. 
 
Further reading: 
CONSORT: http://www.consort-statement.org 
Greenhalgh T. How to read a paper: Statistics for the 
non-statistician. I: Different types of data need different 
statistical tests. BMJ 1997;315:364-366 
Bland JM, Altman DG. Statistical methods for 
assessing agreement between two methods of clinical 
measurement. Lancet 1986;1:307-310. Available online 
at http://www-users.york.ac.uk/~mb55/meas/ba.htm 
BMJ Statistics Notes: http://www-
users.york.ac.uk/~mb55/pubs/pbstnote.htm 
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